🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a first in human, open-label, multi-center Phase 1 / 2 study to eva...
Status
Recruiting
Location
Sylvester Comprehensive Cancer Center - Miami
Start Date
2022-04-04
Trial ID
NCT05267626
Treatments Being Tested
This is a single arm, open-label phase Ib study of combining eribulin mesyl...
Status
Terminated
Location
Univeristy of Iowa Hospital and Clinics
Start Date
2018-06-12
Trial ID
NCT03502681
Treatments Being Tested
This is a 2 part Phase I/II clinical trial evaluating the safety, tolerabil...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2018-05-29
Trial ID
NCT03490292
Treatments Being Tested
This study consists of 2 parts: Dose Escalation Part 1 and Dose Expansion P...
Status
Terminated
Location
CHU Sainte-Justine
Start Date
2021-12-03
Trial ID
NCT05081180
Treatments Being Tested
The study is primarily designed to assess the safety and tolerability of es...
Status
Completed
Location
Cross Cancer Center Dept Medicine
Start Date
2017-10-10
Trial ID
NCT03270176
Treatments Being Tested
This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacoki...
Status
Terminated
Location
UCSD Medical Center - Encinitas
Start Date
2015-11-09
Trial ID
NCT02554812
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation and expansion study, evaluat...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #6
Start Date
2019-03-20
Trial ID
NCT03845166
Treatments Being Tested
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2...
Status
Unknown
Location
University of Colorado Anschutz Medical Campus
Start Date
2019-03-19
Trial ID
NCT03787602
This was a Phase 1, open-label, dose-escalation trial of avelumab (antibody...
Status
Completed
Location
Research site
Start Date
2013-09-02
Trial ID
NCT01943461
Treatments Being Tested
A modular, first time in human, open label, multiple dose, accelerated esca...
Status
Recruiting
Location
Institut Jules Bordet
Start Date
2023-05-30
Trial ID
NCT04954599
Treatments Being Tested